BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Acquires 46,421 Shares of Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) major shareholder Saba Capital Management, L.P. purchased 46,421 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was purchased at an average cost of 16.33 per share, with a total value of 758,054.93. Following the purchase, the insider now owns 20,538,431 shares in the company, valued at approximately 335,392,578.23. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

  • On Thursday, March 28th, Saba Capital Management, L.P. purchased 16,297 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 16.33 per share, with a total value of 266,130.01.
  • On Tuesday, March 26th, Saba Capital Management, L.P. purchased 129,372 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 16.32 per share, with a total value of 2,111,351.04.
  • On Thursday, February 29th, Saba Capital Management, L.P. bought 46,958 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 16.30 per share, with a total value of 765,415.40.
  • On Monday, February 26th, Saba Capital Management, L.P. bought 113,930 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 16.34 per share, with a total value of 1,861,616.20.
  • On Thursday, February 22nd, Saba Capital Management, L.P. bought 154,932 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 16.13 per share, with a total value of 2,499,053.16.
  • On Tuesday, February 20th, Saba Capital Management, L.P. bought 193,297 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.92 per share, with a total value of 3,077,288.24.
  • On Thursday, February 15th, Saba Capital Management, L.P. bought 41,462 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.82 per share, with a total value of 655,928.84.
  • On Monday, February 12th, Saba Capital Management, L.P. bought 83,360 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 16.08 per share, with a total value of 1,340,428.80.
  • On Friday, February 9th, Saba Capital Management, L.P. bought 122,094 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.97 per share, with a total value of 1,949,841.18.
  • On Wednesday, February 7th, Saba Capital Management, L.P. bought 100,354 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.81 per share, with a total value of 1,586,596.74.

BlackRock Health Sciences Term Trust Price Performance

BMEZ opened at 15.81 on Thursday. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.95. The business has a 50 day moving average of 16.05 and a 200-day moving average of 14.85.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Monday, April 15th will be given a $0.09 dividend. The ex-dividend date of this dividend is Friday, April 12th. This represents a $1.08 annualized dividend and a dividend yield of 6.83%.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds have recently modified their holdings of BMEZ. Saba Capital Management L.P. boosted its position in shares of BlackRock Health Sciences Term Trust by 28.0% in the third quarter. Saba Capital Management L.P. now owns 8,347,664 shares of the company’s stock valued at $120,290,000 after acquiring an additional 1,827,094 shares during the period. Lazard Asset Management LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 344.8% in the third quarter. Lazard Asset Management LLC now owns 642,545 shares of the company’s stock valued at $9,259,000 after purchasing an additional 498,079 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the third quarter valued at $3,827,000. Karpus Management Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 27.1% in the fourth quarter. Karpus Management Inc. now owns 1,217,589 shares of the company’s stock valued at $17,838,000 after purchasing an additional 259,464 shares in the last quarter. Finally, Wolverine Asset Management LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 260.3% in the fourth quarter. Wolverine Asset Management LLC now owns 274,318 shares of the company’s stock valued at $4,019,000 after purchasing an additional 198,177 shares in the last quarter.

About BlackRock Health Sciences Term Trust

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Read More

Insider Buying and Selling by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.